Glz 80mg Tablet contains Gliclazide 80mg, an oral hypoglycemic agent belonging to the sulfonylurea class, primarily indicated for the management of type 2 diabetes mellitus. Gliclazide acts by stimulating insulin secretion from the pancreatic beta cells, thereby improving glycemic control in patients with non-insulin-dependent diabetes. This medication is typically prescribed when diet, exercise, and weight reduction alone have not achieved adequate blood glucose regulation. Glz 80mg Tablet helps reduce both fasting and postprandial blood glucose levels, contributing to the prevention of long-term diabetic complications such as neuropathy, nephropathy, and retinopathy. It should be used under medical supervision, with dosage individualized based on patient response and glycemic targets. Common side effects may include hypoglycemia, gastrointestinal disturbances, and allergic reactions; therefore, patients should be monitored for symptoms of low blood sugar and advised on appropriate management. Caution is warranted in patients with hepatic or renal impairment, and it is contraindicated in type 1 diabetes, diabetic ketoacidosis, and pregnancy. Regular blood glucose monitoring and periodic assessment of renal and hepatic function are recommended during therapy. Glz 80mg Tablet offers an effective option for glycemic control as part of a comprehensive diabetes management plan.